WhiskerBlock Beta

WhiskerBlock Beta is a consumer biotechnology product developed by Pacagen to mitigate dog allergen exposure in indoor environments. The active component consists of alpaca-derived single-domain antibodies, or nanobodies, engineered to bind specifically to Can f 1 and Can f 2, the primary allergens found in dog dander, saliva, and urine. Unlike traditional allergy treatments that target the human immune response, WhiskerBlock Beta is applied as a topical environmental spray to surfaces such as furniture, carpets, and pet bedding. By neutralizing these allergens at the source, the product prevents them from becoming airborne and triggering allergic symptoms like rhinitis or asthma in sensitive individuals. It is marketed as a non-toxic, safe, and drug-free solution for managing pet allergies in the home.

Brand names

WhiskerBlock BetaDog Allergen Neutralizing Spray

Other names

WhiskerBlock Beta protein technology